Dassault Systèmes Acquires Medidata to Lead Digital Transformation in Personalized Medicine

On October 31, 2019, VCBeat (WeChat ID: vcbeat) learned from foreign media reports that French technology company Dassault Systèmes announced the acquisition of Medidata, a global leading provider of cloud solutions for life sciences clinical research. Under the terms of the agreement, Dassault Systèmes will acquire all issued and outstanding common shares of Medidata for $92.25 per share in cash, in a transaction valued at approximately $5.8 billion.

Following the completion of this acquisition, Dassault Systèmes will integrate its 3DEXPERIENCE platform with Medidata’s Clinical Trial platform, connecting the various touchpoints across research, development, manufacturing, clinical trials, and commercial deployment within the entire healthcare ecosystem.

The 3DEXPERIENCE platform integrates modeling, simulation, data science, artificial intelligence, and virtual world collaboration to enable sustainable innovation in the life sciences. Leveraging the 3DEXPERIENCE platform and Medidata solutions, life sciences companies can enhance operational efficiency, improve the efficiency of clinical trials, design, and drug development, and create tailored treatment regimens that deliver tangible benefits to patients.

Medidata’s clinical expertise and cloud-based technology solutions are driving the intelligent development and commercialization of therapies. Dassault Systemes’ acquisition of Medidata will position it to lead the digital transformation of life sciences in an era defined by personalized medicine and patient-centric experiences. The comprehensive and in-depth healthcare services provided reflect Dassault Systemes’ profound understanding of healthcare, its ecosystem, and market demands.

Building on its historical strengths and further leveraging real-world data, Dassault Systemes can close the loop, engaging every organization and individual—research laboratories, clinical trial sites, manufacturing facilities, and patients—in the process of therapeutic innovation and commercialization. This enriches the entire continuum through data-driven decision-making and continuous knowledge capitalization.

Today’s life sciences companies are following the development path of the aerospace, automotive, high-tech, and many other industries that have already embraced digital transformation in the experience economy, delivering not just products but personalized experiences to their customers. Addressing the complexities of personalized medicine requires a digital platform to connect the dots between people, ideas, and data. The combination of Dassault Systèmes and Medidata solutions enables this connectivity.

Bernard Charlès, Vice Chairman and CEO of Dassault Systemes, stated: “We warmly welcome Medidata’s solutions and its exceptional talent, who bring us an unparalleled portfolio that helps us realize our vision for a better future. Grounded in a scientific culture and deep expertise in the life sciences industry, Medidata will become a core brand within our Information Intelligence domain. The 3DEXPERIENCE platform will be instrumental for healthcare innovators in anticipating and driving the industry’s transformation toward precision healthcare in the 21st century. The virtual world will unlock new possibilities, transforming not only research and science, but also the entire pharmaceutical, medical device, and healthcare industries.”

“Medidata and the Dassault Systèmes team have long shared a common vision of fostering sustainable innovation and improving lives,” said Tarek Sherif, Co-founder, Chairman, and CEO of Medidata. “We are now fully committed to comprehensive integration, which will benefit our customers and partners. Through the integration of Dassault Systèmes and Medidata, we have never been better positioned to realize our ambition of delivering the right treatment to the right patient at the right time.”

Dassault Systèmes is a comprehensive software provider. Headquartered in Paris, France, the company offers the 3DEXPERIENCE platform, with applications spanning 3D modeling, social collaboration, information intelligence and content, and simulation. Its services cover various sectors, including commercial aviation. The company’s solutions include SolidWorks, CATIA, SIMULIA, DELMIA, ENOVIA, 3DVIA, and Exalead, enabling users to create, share, and experience 3D content.

Medidata, founded in 1999 and headquartered in New York, USA, is a leading global provider of cloud-based solutions for clinical research in the life sciences industry. With its integrated service platform, pioneering data analytics, and world-class expertise, Medidata supports more than 1,000 pharmaceutical companies, biotechnology firms, medical device manufacturers, academic medical centers, and contract research organizations (CROs) worldwide in the development of novel therapies.

(Compiled by Wang Fang)